Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication November 22, 2005
- Accepted for publication March 27, 2006
- Published online July 3, 2006.
Copyright & Usage
© 2006 by Society of Nuclear Medicine
Author Information
- Laura E. Lantry 1 ,
- Enrico Cappelletti 2 ,
- Mary Ellen Maddalena 1 ,
- Jaclyn S. Fox 1 ,
- Weiwei Feng 1 ,
- Jianqing Chen 1 ,
- Regi Thomas 1 ,
- Stephen M. Eaton 1 ,
- Nancy J. Bogdan 1 ,
- Thangavel Arunachalam 1 ,
- Jean Claude Reubi 3 ,
- Natarajan Raju 1 ,
- Edmund C. Metcalfe 1 ,
- Luciano Lattuada 2 ,
- Karen E. Linder 1 ,
- Rolf E. Swenson 1 ,
- Michael F. Tweedle 1 and
- Adrian D. Nunn 1
- 1Ernst Felder Laboratories, Bracco Research USA Inc., Princeton, New Jersey; 2Bracco Imaging S.p.A., Milan, Italy; and 3Institute of Pathology, University of Bern, Bern, Switzerland
- For correspondence or reprints contact: Laura E. Lantry, PhD, Discovery Biology, Ernst Felder Laboratories, Bracco Research USA Inc., 305 College Rd. East, Princeton, NJ 08540-6608. E-mail: Laura.Lantry{at}bru.bracco.com
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Exploring the signaling space of a GPCR using bivalent ligands with a rigid oligoproline backbone
- 68Ga/177Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology
- Bombesin-Targeted PET of Prostate Cancer
- In Vitro and In Vivo Application of Radiolabeled Gastrin-Releasing Peptide Receptor Ligands in Breast Cancer
- A Comparative Study of Radiolabeled Bombesin Analogs for the PET Imaging of Prostate Cancer
- Targeted Radiotherapy of Prostate Cancer with a Gastrin-Releasing Peptide Receptor Antagonist Is Effective as Monotherapy and in Combination with Rapamycin
- PET of Tumors Expressing Gastrin-Releasing Peptide Receptor with an 18F-Labeled Bombesin Analog
- Bombesin Antagonist-Based Radioligands for Translational Nuclear Imaging of Gastrin-Releasing Peptide Receptor-Positive Tumors
- Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (213Bi-DOTA-PESIN and 213Bi-AMBA versus177Lu-DOTA-PESIN)
- Multimodality Imaging and Preclinical Evaluation of 177Lu-AMBA for Human Prostate Tumours in a Murine Model
- 177Lu-AMBA Biodistribution, Radiotherapeutic Efficacy, Imaging, and Autoradiography in Prostate Cancer Models with Low GRP-R Expression
- Evaluation of a 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid-Conjugated Bombesin-Based Radioantagonist for the Labeling with Single-Photon Emission Computed Tomography, Positron Emission Tomography, and Therapeutic Radionuclides
- Small-Animal PET of Tumors with 64Cu-Labeled RGD-Bombesin Heterodimer
- High expression of gastrin-releasing peptide receptors in the vascular bed of urinary tract cancers: promising candidates for vascular targeting applications
- Peptide-Based Probes for Cancer Imaging
- International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States
- Bombesin Receptor Antagonists May Be Preferable to Agonists for Tumor Targeting
- In Vivo Evaluation and Small-Animal PET/CT of a Prostate Cancer Mouse Model Using 64Cu Bombesin Analogs: Side-by-Side Comparison of the CB-TE2A and DOTA Chelation Systems